Neil W. Gibson

Insider Reports History

Identity 1 fact
Location
San Diego, CA
SEC filing record 1 fact
Filing signature
/s/ Andrew R. Neill, Attorney-in-Fact for Neil W. Gibson
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Neil W. Gibson:

Form 4 holding Director

Shattuck Labs, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
33,150
Estimated value
Report date
14 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Instil Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
6,500
Estimated value
Report date
28 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TCR2 THERAPEUTICS INC.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
01 Jun 2023
Price
$0.7400
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Neil W. Gibson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .